Aortic Arch Calcification and Bone-Associated Molecules in Peritoneal Dialysis Patients.
Aortic Arch Calcification and Bone-Associated Molecules in Peritoneal Dialysis Patients.
复制标题
腹膜透析患者的主动脉弓钙化和骨相关分子。
DOI:
10.1159/000496657
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Nitta K.
中科院分区:
文献类型:
--
作者:
Tsukada M;Miwa N;Hanafusa N;Tanaka N;Tsuchiya K;Nitta K.
Background/AimsAortic arch calcification (AoAC) is a fatal complication in dialysis. AoAC progression-related molecules in continuous ambulatory peritoneal dialysis (CAPD) remain unclear.MethodsAoAC was estimated using plain chest radiography scoring (AoACS) in 30 CAPD patients (age 49.3±13.4 years). AoAC progression was defined as increased AoACS on follow-up chest X-ray at the end of the study (progressors). Fibroblast growth factor-23 and osteoprotegerin (OPG) were measured.ResultsMedian follow-up was 38.5 months. Progressors were older, had shorter PD vintage, higher body mass index, and higher serum OPG levels (255.6±109.2 pg/mL) than nonprogressors (183.4±68.2 pg/mL; p= 0.0400). Progressors also showed higher pulse pressure (62.4±20.0 mm Hg) and pulse wave velocity (1,909.9±310.6 cm/s) than nonprogressors (48.5±13.6 mm Hg; p= 0.0030 and 1,390.1±252.8 cm/s; p= 0.0005, respectively).ConclusionAoAC progression was associated with increased aortic stiffness. OPG may be associated with AoAC progression in CAPD.